Standout Papers
Citation Impact
Citing Papers
Molecular biomarkers in idiopathic pulmonary fibrosis
2014
Adult-onset pulmonary fibrosis caused by mutations in telomerase
2007
Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18–64 years old
2016
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Sorafenib ameliorates bleomycin-induced pulmonary fibrosis: potential roles in the inhibition of epithelial–mesenchymal transition and fibroblast activation
2013
Population Burden of Long‐Term Survivorship After Severe Sepsis in Older Americans
2012
Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature
2014
The Increasing Secondary Care Burden of Idiopathic Pulmonary Fibrosis
2013
Minimal Clinically Important Differences for the Modified Rodnan Skin Score: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)
2019
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
Increasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
2014
Interstitial Lung Disease: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases
2014
Drug Treatment of Idiopathic Pulmonary Fibrosis
2016
The minimal important difference of the King's Brief Interstitial Lung Disease Questionnaire (K-BILD) and forced vital capacity in interstitial lung disease
2013
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis
2009
Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study
2015
Idiopathic pulmonary fibrosis
2017 Standout
Pulmonary fibrosis in the era of stratified medicine
2016
Osteoporosis
2019 Standout
Idiopathic pulmonary fibrosis: effects and optimal management of comorbidities
2016
The role of mitochondrial dysfunction in sepsis-induced multi-organ failure
2013
WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis
2009
Idiopathic Pulmonary Fibrosis and Emphysema
2009
Fibrosing interstitial lung diseases: knowns and unknowns
2019
Early Interstitial Lung Disease in Familial Pulmonary Fibrosis
2007
Sex differences in physiological progression of idiopathic pulmonary fibrosis
2008
Design of the INPULSIS™ trials: Two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis
2014
Lung Fibroblasts from Patients with Idiopathic Pulmonary Fibrosis Exhibit Genome-Wide Differences in DNA Methylation Compared to Fibroblasts from Nonfibrotic Lung
2014
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
2009
Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis
2008
A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
2014 Standout
Relative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
2012
Time to Treatment and Mortality during Mandated Emergency Care for Sepsis
2017 Standout
Prevalence and impact of coronary artery disease in idiopathic pulmonary fibrosis
2010
Echocardiography and brain natriuretic peptide as prognostic indicators in idiopathic pulmonary fibrosis
2008
Drotrecogin Alfa (Activated) in Adults with Septic Shock
2012 Standout
A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis
2013
Kinetics of Neutrophils in Mice Exposed to Radiation and/or Granulocyte Colony-Stimulating Factor Treatment
2013
Idiopathic Pulmonary Fibrosis
2007
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Prevalence and Outcomes of Pulmonary Arterial Hypertension in Advanced Idiopathic Pulmonary Fibrosis
2006
Molecular Phenotypes Distinguish Patients with Relatively Stable from Progressive Idiopathic Pulmonary Fibrosis (IPF)
2009
Interventions to improve symptoms and quality of life of patients with fibrotic interstitial lung disease: a systematic review of the literature
2012
Hallmarks of aging: An expanding universe
2023 Standout
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
2009
Identification of Early Interstitial Lung Disease in Smokers from the COPDGene Study
2009
Body Mass Index and Mortality in Patients With Idiopathic Pulmonary Fibrosis
2007
National estimates of severe sepsis in United States emergency departments
2007
Significance of Pulmonary Arterial Pressure and Diffusion Capacity of the Lung as Prognosticator in Patients With Idiopathic Pulmonary Fibrosis
2007
Crohn's disease
2012 Standout
The diagnosis of idiopathic pulmonary fibrosis: current and future approaches
2016
Peripheral depletion of NK cells and imbalance of the Treg/Th17 axis in idiopathic pulmonary fibrosis patients
2014
Mortality from Pulmonary Fibrosis Increased in the United States from 1992 to 2003
2007
Systemic sclerosis
2017 Standout
Treatment of Idiopathic Pulmonary Fibrosis with Etanercept
2008
Incidence, Prevalence, and Clinical Course of Idiopathic Pulmonary Fibrosis
2009
Global Impairment of CD4 + CD25 + FOXP3 + Regulatory T Cells in Idiopathic Pulmonary Fibrosis
2009
Efficacy of pirfenidone in patients with idiopathic pulmonary fibrosis with more preserved lung function
2016
Idiopathic pulmonary fibrosis in US Medicare beneficiaries aged 65 years and older: incidence, prevalence, and survival, 2001–11
2014
Management of Sepsis
2011
A Single Dose of Intravenous Zoledronate Prevents Glucocorticoid Therapy-Associated Bone Loss in Acute Flare of Crohn's Disease, a Randomized Controlled Trial
2011
Severe Sepsis and Septic Shock
2013 Standout
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada
2016
Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis
2016
Clinical and economic burden of idiopathic pulmonary fibrosis: a retrospective cohort study
2016
Osteoporosis: now and the future
2011 Standout
Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?
2016
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Nonresolving Inflammation
2010 Standout
Long-term mortality and quality of life in sepsis: A systematic review*
2010
Quantitative Computed Tomography Imaging of Interstitial Lung Diseases
2013
Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
2016
The 6 minute walk in idiopathic pulmonary fibrosis: longitudinal changes and minimum important difference
2009
Dissecting fibrosis: therapeutic insights from the small-molecule toolbox
2015
Pirfenidone in idiopathic pulmonary fibrosis: the CAPACITY program
2011
Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema
2010
Asthma
2017 Standout
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER)
2016
Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock
2013
Idiopathic Pulmonary Fibrosis and Pulmonary Hypertension
2007
The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis
2008
Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials
2016
Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe
2009
Epidemiology of Severe Sepsis in Intensive Care Units in the Slovak Republic
2005
Impact of Comorbidities on Mortality in Patients with Idiopathic Pulmonary Fibrosis
2016
The natural history of progressive fibrosing interstitial lung diseases
2019
Broad-Spectrum Antibiotic or G-CSF as Potential Countermeasures for Impaired Control of Bacterial Infection Associated with an SPE Exposure during Spaceflight
2015 StandoutNobel
The Economic and Humanistic Burden of Severe Sepsis
2015
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Sepsis and septic shock
2018 Standout
Cytokine-Like Factor 1 Gene Expression Is Enriched in Idiopathic Pulmonary Fibrosis and Drives the Accumulation of CD4+ T Cells in Murine Lungs
2012
Pulmonary rehabilitation improves long-term outcomes in interstitial lung disease: A prospective cohort study
2013
Telomere dysfunction in alveolar epithelial cells causes lung remodeling and fibrosis
2016
Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trials
2015
Idiopathic pulmonary fibrosis
2017 Standout
Hydrocortisone Therapy for Patients with Septic Shock
2008 Standout
Senescent Cells: A Novel Therapeutic Target for Aging and Age-Related Diseases
2012
Hindlimb Suspension and SPE-Like Radiation Impairs Clearance of Bacterial Infections
2014 StandoutNobel
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
2009 Standout
Does Chronic Microaspiration Cause Idiopathic Pulmonary Fibrosis?
2010
Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials
2013
EMT: 2016
2016 Standout
Incidence of sepsis in hospitalized patients
2006
Accelerated Variant of Idiopathic Pulmonary Fibrosis: Clinical Behavior and Gene Expression Pattern
2007
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
International Guidelines for the Selection of Lung Transplant Candidates: 2006 Update—A Consensus Report From the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation
2006
Epidemiology of Idiopathic Pulmonary Fibrosis in Northern Italy
2016
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
2011
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
2009
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review
2015
Natural history of idiopathic pulmonary fibrosis
2015
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial
2017
Role of diabetes mellitus and gastro-oesophageal reflux in the aetiology of idiopathic pulmonary fibrosis
2008
Comparing effects of mTR and mTERT deletion on gene expression and DNA damage response: a critical examination of telomere length maintenance-independent roles of telomerase
2009 StandoutNobel
Safety and tolerability of acetylcysteine and pirfenidone combination therapy in idiopathic pulmonary fibrosis: a randomised, double-blind, placebo-controlled, phase 2 trial
2016
Interstitial Lung Abnormalities in a CT Lung Cancer Screening Population: Prevalence and Progression Rate
2013
Gastroesophageal reflux in patients with idiopathic pulmonary fibrosis referred for lung transplantation
2007
The Association of Sepsis Syndrome and Organ Dysfunction With Mortality in Emergency Department Patients With Suspected Infection
2006
Classification and Natural History of the Idiopathic Interstitial Pneumonias
2006
Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial
2009
Seasonal Variation
2008
The role of senescent cells in ageing
2014 StandoutNature
Idiopathic pulmonary fibrosis
2011 Standout
Clinical Predictors of a Diagnosis of Idiopathic Pulmonary Fibrosis
2010
Acute exacerbation of idiopathic pulmonary fibrosis: Role of Chlamydophila pneumoniae infection
2007
Identifying Patients With Severe Sepsis Using Administrative Claims
2012
Clinical Potential of RANKL Inhibition for the Management of Postmenopausal Osteoporosis and Other Metabolic Bone Diseases
2008
Occupational Risks for Idiopathic Pulmonary Fibrosis Mortality in the United States
2008
International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
2009 Standout
Osteoporosis: burden, health care provision and opportunities in the EU
2011
Serial Development of Pulmonary Hypertension in Patients with Idiopathic Pulmonary Fibrosis
2008
Telomere Shortening in Familial and Sporadic Pulmonary Fibrosis
2008
Benchmarking the Incidence and Mortality of Severe Sepsis in the United States*
2013 Standout
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
2014 Standout
Antifibrotic activities of pirfenidone in animal models
2011
Imatinib Treatment for Idiopathic Pulmonary Fibrosis
2009
Sepsis in European intensive care units: Results of the SOAP study*
2006 Standout
Mycophenolate Versus Cyclophosphamide for Progressive Interstitial Lung Disease Associated with Systemic Sclerosis: A 2-Year Case Control Study
2013
National variation in United States sepsis mortality: a descriptive study
2010
Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
2016
Epidemiology of idiopathic pulmonary fibrosis
2013
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis–associated interstitial lung disease trials
2015
Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study
2012
Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial
2013
Incidence and long-term outcome of sepsis on general wards and in an ICU at the General Hospital of Vienna: an observational cohort study
2013
Idiopathic Pulmonary Fibrosis
2006
Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis
2010 Standout
Revealing the Pathogenic and Aging-related Mechanisms of the Enigmatic Idiopathic Pulmonary Fibrosis. An Integral Model
2014
Interstitial Lung Abnormalities and Reduced Exercise Capacity
2012
The Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
2013
Role of Lung Pericytes and Resident Fibroblasts in the Pathogenesis of Pulmonary Fibrosis
2013
Idiopathic Pulmonary Fibrosis in United States Automated Claims. Incidence, Prevalence, and Algorithm Validation
2015
Peripheral Blood Proteins Predict Mortality in Idiopathic Pulmonary Fibrosis
2011
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
2017
All-Cause Mortality Rate in Patients with Idiopathic Pulmonary Fibrosis. Implications for the Design and Execution of Clinical Trials
2014
Pathologic Regulation of Collagen I by an Aberrant Protein Phosphatase 2A/Histone Deacetylase C4/MicroRNA-29 Signal Axis in Idiopathic Pulmonary Fibrosis Fibroblasts
2015
BUILD-3: A Randomized, Controlled Trial of Bosentan in Idiopathic Pulmonary Fibrosis
2011
Precision Medicine: The New Frontier in Idiopathic Pulmonary Fibrosis
2016
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
The Association between Idiopathic Pulmonary Fibrosis and Vascular Disease
2008
First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis
2010
Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways
2016
Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
2017
Assessment of Clinical Criteria for Sepsis
2016 Standout
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
2016 Standout
Diagnosis of idiopathic pulmonary fibrosis with high-resolution CT in patients with little or no radiological evidence of honeycombing: secondary analysis of a randomised, controlled trial
2014
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Acute and subacute idiopathic interstitial pneumonias
2016
Lung transplantation in IIP : A review
2015
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Subsequent Infections in Survivors of Sepsis
2012
Increasing awareness of sex differences in airway diseases
2015
Design of the PF-ILD trial: a double-blind, randomised, placebo-controlled phase III trial of nintedanib in patients with progressive fibrosing interstitial lung disease
2017
Syndromes of Telomere Shortening
2009
Non-steroid agents for idiopathic pulmonary fibrosis
2010
Pathogenesis of Idiopathic Pulmonary Fibrosis
2013
Global Risk Assessment to Guide Blood Pressure Management in Cardiovascular Disease Prevention
2017
Psychometric properties of the St George’s Respiratory Questionnaire in patients with idiopathic pulmonary fibrosis: insights from the INPULSIS trials
2018
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
A Randomized Trial of Protocol-Based Care for Early Septic Shock
2014 Standout
Immunosuppression in Patients Who Die of Sepsis and Multiple Organ Failure
2011 Standout
Hospital readmission and healthcare utilization following sepsis in community settings
2014
Ionizing Radiation Selectively Reduces Skin Regulatory T Cells and Alters Immune Function
2014 StandoutNobel
Comprehensive assessment of the long‐term safety of pirfenidone in patients with idiopathic pulmonary fibrosis
2014
Developing a New Definition and Assessing New Clinical Criteria for Septic Shock
2016 Standout
A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
2012 Standout
Alveolar epithelial cells express mesenchymal proteins in patients with idiopathic pulmonary fibrosis
2011
Idiopathic Pulmonary Fibrosis
2018 Standout
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
2010
Epidemiological studies in idiopathic pulmonary fibrosis: pitfalls in methodologies and data interpretation
2015
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Works of Derek Weycker being referenced
Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis
2016
Compliance with osteoporosis drug therapy and risk of fracture
2006
Comparative Effectiveness of Filgrastim, Pegfilgrastim, and Sargramostim as Prophylaxis Against Hospitalization for Neutropenic Complications in Patients With Cancer Receiving Chemotherapy
2011
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis
2010
Unified baseline and longitudinal mortality prediction in idiopathic pulmonary fibrosis
2015
Compliance with drug therapy for postmenopausal osteoporosis
2006
Long-term mortality and medical care charges in patients with severe sepsis
2003
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
2016
Risk of hospitalization for neutropenic complications of chemotherapy in patients with primary solid tumors receiving pegfilgrastim or filgrastim prophylaxis: A retrospective cohort study
2009
Adherence with bisphosphonate therapy and change in bone mineral density among women with osteoporosis or osteopenia in clinical practice
2012
Risk-Factor Clustering and Cardiovascular Disease Risk in Hypertensive Patients
2007
6-minute walk distance is an independent predictor of mortality in patients with idiopathic pulmonary fibrosis
2013
Validation of test performance characteristics and minimal clinically important difference of the 6-minute walk test in patients with idiopathic pulmonary fibrosis
2015
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
2006 Standout
Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary Fibrosis
2011
Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis
2011
Predictors of Mortality Poorly Predict Common Measures of Disease Progression in Idiopathic Pulmonary Fibrosis
2016
Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis
2017
Predictors of Mortality in Patients with Idiopathic Pulmonary Fibrosis (IPF).
2009
The Clinical Course of Patients with Idiopathic Pulmonary Fibrosis
2005
CATEGORICAL DECLINES IN PERCENT PREDICTED FORCED VITAL CAPACITY (PP-FVC) ARE ASSOCIATED WITH A GRADED RISK OF DEATH IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
2008
Prevalence and Economic Burden of Bronchiectasis
2005